Abstract
The extract from leaves of Genipa americana L., Rubiaceae, has antichagasic effect. The major components of this extract, arabinogalactan-glycoconjugate fractions (PFI and PFII), have shown similar biological effects of the crude extract, becoming interesting to evaluate the antichagasic effect of PFI and PFII. This work aimed to access the trypanocidal effect of PFI and PFII against the benznidazole-resistant Trypanosoma cruzi Y strain and to investigate the mechanism of action. PFI and PFII were evaluated on epimastigote (24, 48, 72 h), trypomastigote (24 h), and amastigote (24 and 48 h) forms. The cytotoxicity on LLC-MK2 cells was made by MTT assay. Flow cytometry analysis with PE-annexin V (Ax), 7-AAD, and DCFH-DA staining and scanning electron microscopy (SEM) were performed in epimastigote forms for evaluation of the cell death pathway. PFI showed effect against epimastigote forms (EC50/24 h = 580 ± 0.17 μg/ml; EC50/48 h = 530 ± 0.13 μg/ml; EC50/72 h = 500 ± 0.14 μg/ml), while PFII did not show effect on any tested concentrations. In trypomastigotes, the PFI and PFII showed effect with EC50 values of 100 ± 0.09 and 23 ± 0.06 μg/ml respectively. PFI and PFII were also able to decrease amastigotes/100 cells parameter. PFI and PFII were not cytotoxic in LLC-MK2 cells at the highest tested concentration, resulting in selectivity index (SI) higher than 15 for PFI and higher than 65 for PFII. The increase in labeling of 7-AAD and DCFH-DA fluorescence on cytometry flow assays suggested necrosis as the cell death pathway of PFI in epimastigotes of T. cruzi, being confirmed by pores in the membrane observed on SEM. PFI and PFII are partially responsible by the trypanocidal effect of the crude extract of G. americana, with PFI showing the same action mechanism of crude extract and PFII being the most selective and potent fraction, presenting the biotechnological potential for antichagasic natural products.
Graphical abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Genipa americana L., Rubiaceae, traditionally called “jenipapeiro,” has a wide geographic distribution in Brazil (Corrêa 1984). It is used in folk medicine as an antimalarial plant by indigenous people in Amazonas (Kffuri et al. 2016) and extracts from leaves have demonstrated activity against protozoan Plasmodium berghei and Plasmodium falciparum (Deharo et al. 2001), showing antiparasitic potential.
Chagas disease, also known as American trypanosomiasis, a parasitic tropical disease caused by the protozoan Trypanosoma cruzi, affects approximately 7 million people worldwide. The complications related to this disease are related to approximately 12,000 deaths of people each year. The parasites are mainly transmitted to humans by the infected feces of blood-sucking triatomine bugs, known as the “kissing bug” (WHO 2020). The only two drugs to treat Chagas disease, benznidazole (BZ) and nifurtimox (NFX), have limited efficacy and several adverse effects, showing effectiveness only at the acute phase (Molina et al. 2015; WHO 2020). Thus, the search for new antichagasic substances is necessary and natural products are sources of compounds with trypanocidal activity and they may provide pharmacological tools against Chagas disease (Don and Ioset 2014; Newman and Cragg 2020; Morais et al. 2020).
Recently, we demonstrated trypanocidal action of a polysaccharide extract from G. americana leaves against a benznidazole-resistant strain of T. cruzi (Souza et al. 2018). Two arabinogalactan-glycoconjugates from this extract were separated and characterized, being mainly composed of arabinose, galactose, and uronic acid. They are denominated as PFI and PFII, having high and low molecular weight respectively (Madeira et al. 2018). These two arabinogalactan-glycoconjugate fractions are partially responsible for some biological effects of the polysaccharide extract from G. americana leaves (Madeira et al. 2018, 2020). Thus, considering the ethnopharmacological uses against protozoan, this work aimed to evaluate the trypanocidal activity of arabinogalactan-glycoconjugate fractions of G. americana leaves against T. cruzi Y strain and to assess the action mechanism.
Material and methods
Chemicals
Benznidazole (BZ) was kindly donated by the Lafepe (Laboratório Farmacêutico do Estado de Pernambuco, Brazil). DEAE-cellulose and DMEM were obtained from Vitrocell, São Paulo, Brazil. Fetal bovine serum (FBS) was obtained from Invitrogen (Grand Island, NY, USA). PE conjugated to annexin V/7-AAD was obtained from BD Pharmingen, CA, USA, and DCFH-DA from Sigma-Aldrich™, St. Louis, USA. LIT medium was obtained from HiMedia Laboratories (Mumbai, Ind), sodium dodecyl sulfate (SDS) was obtained from Vetec (São Paulo, Brazil), and 3-[4,5-dimethylthiazol-2-yl]2,5-diphenytetrazolium bromide formazan (MTT) was obtained from Amresco (OH, USA). All other reagents were of analytical grade.
Obtaining of polysaccharides from Genipa americana leaves
Leaves of Genipa americana L., Rubiaceae, were obtained in the district of Custodio-Quixadá, state of Ceará, Brazil (5° 0′ 56.498″ S, 39° 6′ 58.889″ W) and identified by an expert of State University of Ceará. A plant exsiccate was deposited at Prisco Bezerra Herbarium of the Federal University of Ceará (No. 4683). The leaves were washed, dried at 40 °C, grounded to powder, and suspended in methanol (1:50 w/v, 76 °C, 2 h). After that, this suspension was filtered twice and the insoluble material was extracted with 0.1 M NaOH (1:50 w/v, 97 °C) three times, resulting in alkaline extracts. These extracts were pooled, neutralized, precipitated with ethanol, and centrifuged. The supernatant was dialyzed for 72 h and centrifuged and the final supernatant was lyophilized, obtaining the extract of G. americana—GaEPL (Souza et al. 2015).
Extract of G. americana was dissolved in distilled water (2:1, w/v) and fractionated by ion-exchange chromatography (DEAE-cellulose). The column was equilibrated, washed, and acidic polysaccharides eluted (60 ml/h) in a stepwise method with 0.1–1.0 M NaCl. The major fractions of the acidic arabinogalactan-glycoconjugate were eluted with NaCl 0.1 mol/l (PFI) and 0.25 mol/l (PFII), pooled, dialyzed, and lyophilized. The chemical analysis of fractions revealed higher content of carbohydrate (PFI: 36% (9% uronic acid), PFII: 23% (30% uronic acid)) than of proteins (PFI: 4%, PFII: 5%). The dosage of polyphenols revealed the presence of these compounds (PFI: 0.77 mg/g; PFII: 0.81 mg/g) in fractions. PFI is composed mainly by 27% of arabinose, 23% of galactose, 15% of glucose, 16% of fucose, 7% of xylose, 7% of rhamnose, and 5% of mannose, while PFII is composed mainly by 48% of arabinose, 23% of galactose, 4.5% of glucose, 2% of fucose, 10% of xylose, 12% of rhamnose, and 0.5% of mannose (Madeira et al. 2018).
Cells and parasites culture conditions
LLC-MK2 cells (ATCC CCL-7), epimastigote and trypomastigote forms of T. cruzi Y strain were donated by the Chemistry Laboratory of the Biochemistry Institute (University of São Paulo, São Paulo, Brazil). LLC-MK2 were maintained in DMEM (Vitrocell, São Paulo, Brazil) supplemented with 10% of fetal bovine serum (FBS) and 1% antibiotics (penicillin 100 UI/ml and streptomycin 100 μg/ml) at 37 °C and 5% CO2 atmosphere.
Epimastigote forms of T. cruzi Y strain were maintained at 28 °C in liver infusion tryptose (LIT) with 10% FBS and antibiotics (penicillin 100 UI/ml and streptomycin 100 μg/ml). Trypomastigote forms were obtained by the infection of LLC-MK2 cells in DMEM with 2% FBS and antibiotics at 37 °C in a 5% CO2 atmosphere.
Effects against Trypanosoma cruzi epimastigote and trypomastigote forms
Epimastigote and trypomastigote forms of T. cruzi (106 cells/ml) were plated on their respective culture conditions and incubated PFI or PFII (2.92–1500 μg/ml), positive control BZ (1.56–200 μg/ml), or negative control (PBS) at 24, 48, and 72 h for epimastigote forms and 24 h for trypomastigote forms. After incubation, parasite viability was determined in a Neubauer chamber. The concentration correspondent to 50% of viability (EC50) was calculated by nonlinear regression, being 100% of viability the value of negative control (da Rodrigues et al. 2014).
Cytotoxicity to LLC-MK2 cells
LLC-MK2 cells (105 cells/ml) were plated in a 96-well microplate and incubated at 37 °C in a 5% CO2 atmosphere for 24 h. After that, they are treated with different concentrations of PFI or PFII (2.92–1500 μg/ml), BZ (1.56–200 μg/ml), or PBS and incubated for 24 h. MTT assays were performed and reading at 570 nm by a microplate reader (Biochrom® Asys Expert Plus). The cell viability was calculated considering negative control as 100% of viability. The CC50 was determined by nonlinear regression (Vanden Berghe et al. 2013). The selectivity index (SI) was determined by the formula: CC50 of LLC-MK2/EC50 of trypomastigote forms (Nwaka and Hudson 2006).
Effects against Trypanosoma cruzi amastigote forms
LLC-MK2 cells were seeded in 24-well plates containing glass coverslips (13 mm) and incubated for 24 h in DMEM medium 10% FBS and 1% antibiotics (penicillin 100 UI/ml and streptomycin 100 μg/ml) at 37 °C in a 5% CO2 atmosphere. Subsequently, the cells were infected with trypomastigote forms (20:1) in DMEM 2% FBS and incubated for 48 h. After internalization, LLC-MK2 cells were washed with PBS to remove non-internalized parasites and subsequently treated with EC50 and EC50/2 from trypomastigote forms (50 and 100 μg/ml to PFI and 11.5–23 μg/ml to PFII), while to positive control BZ was used EC50 and 2× EC50 (67 and 134 μg/ml). Infected cells treated with PBS were considered negative control. After incubation for 24 or 48 h at 37 °C, the coverslips were removed, washed, fixed in Bouin’s solution, and submitted to Giemsa coloration (Lima et al. 2016). The number of amastigotes per 100 cells and the percentage of infected cells were determined by counting 300 cells in triplicate.
Cell death pathway assay
Epimastigote forms (106 cell/ml) were treated with PFI at 580 μg/ml, half minimal effective concentration (EC50), to observe the process of death or with PBS to observe normal conditions and incubated for 24 h at 28 °C. Subsequently, cells were washed and labeled with PE-annexin V (Ax) and/or 7AAD (BD Pharmigen, CA, USA) or DCFH-DA (Sigma-Aldrich™, St. Louis, USA), according to the manufacturer’s instructions. Epimastigotes treated with PBS were used as negative controls and flow cytometry assays were performed in triplicate in a FACS Calibur system and analyzed using the Cell Quest software (Becton-Dickinson, CA, USA).
Scanning electron microscopy
To observe the cell death process, epimastigote forms were treated with PFI (EC50/2—290 and EC50—580 μg/ml) and incubated for 24 h. Subsequently, the parasites were fixed for 2 h with 2.5% glutaraldehyde solution (Electron Microscopy Sciences, Hatfield, PA), washed, and dehydrated with progressive concentrations of ethanol. After, samples were dried with CO2 5%, coated with gold, and analyzed in a FEG Quanta 450 scanning electron microscope (FEI, OR, USA). Digital images were acquired and stored in a computer (Lima et al. 2018).
Statistical analysis
The statistical analysis was done using the GraphPad Prism 5 program (GraphPad Software, San Diego, CA, USA). The results were expressed as mean ± S.E.M. and analyzed by ANOVA and Bonferroni’s post-test. Significance was defined as *p < 0.05.
Results and discussion
The polysaccharide extract of G. americana showed activity against all main forms of a benznidazole-resistant T. cruzi strain, suggesting a necrotic pathway with ROS involvement. Therefore, GaEPL can be a source of substances against Chagas disease (Souza et al. 2018). In this work, we evaluated two arabinogalactan-glycoconjugate fractions of this extract.
Fractions obtained from natural extracts with trypanocidal action, such as the leaves of Byrsonima crassifolia, the barks of Gliricidia sepium, and leaves from Lygodium venustum, did not show any effect on epimastigote forms (Berger et al. 1998; Morais-Braga et al. 2013). In this work, one of the fractions of the polysaccharide extract from G. americana leaves showed a higher effect than the crude extract (GaEPL) in epimastigote forms; the fraction PFI showed effect after 24, 48, and 72 h of exposure, showing better activity at 72 h (EC50 = 500 ± 0.14 μg/ml). However, PFII did not present effect in any tested concentrations or times of exposure (Table 1).
About twelve fractions obtained from the ethanolic extract of Neurolaena lobata, only butanol fraction showed a 90% inhibition at concentration 25.6 μg/ml of trypomastigotes, while the others were able only to inhibit at a concentration above 200 μg/ml (Berger et al. 1998). Mafezoli et al. (2000) evaluated the activity of twenty-five fractions isolated from plants of the Rutaceae family against the trypomastigote form of T. cruzi. Among them, only leaves of Almeidea coerulea (butanol fraction) and Conchocarpus inopinatus (fraction dichloromethane) were found active with an EC50 of 940 and 1290 μg/ml respectively. Izumi et al. (2011) studied forty-three fractions of plants of the families Meliaceae and Rutaceae. They found fractions of C. heterophyllus and Galipea carinata were the most active, causing 100% lysis of trypomastigotes with a concentration of 2000 μg/ml. Our results show that PFI and PFII from G. americana have an antiparasitic effect on trypomastigote forms of T. cruzi being able to kill 50% of parasites at 100 and 23 μg/ml concentrations, respectively (Table 1).
In vitro cytotoxicity tests are fundamental because they provide information that guides the experimental design such as to define the studied concentrations of the compound and the time of treatment. Two neolignans obtained from Brazilian northeastern plants were effective against trypomastigotes and did not cause significant death of peritoneal macrophages (Cabral et al. 2010). In contrast, the ethyl acetate fraction of Lygodium venustum leaves at concentrations of 500 and 100 μg/ml showed fibroblasts toxicity of 67 and 30%, respectively, and the methanolic fraction (500 μg/ml) caused toxicity of 53% (Morais-Braga et al. 2013). In the other studies, it was observed that galactomannan of lichen Ramalina celastri did not affect the viability of host cells in concentrations 500 to 2000 μg/ml during 2 h of incubation, while it affected the viability of these cells by approximately 20% for both incubation times at concentrations of 250 to 750 μg/ml (24 h) and 2000 μg/ml (48 h) (Noleto 2002). PFI and PFII in the 24-h exposure period did not show any cytotoxicity at the tested concentrations on LLC-MK2 cells, being considered higher than 1500 μg/ml.
After the evaluation of non-toxic concentrations, the SI of the PFI and PFII were calculated. This evaluation is considered important since a substance is considered promising when it exhibits selectivity on the target cells without significantly damaging the host cell (Nwaka and Hudson 2006). Our results showed SI higher than 15 for PFI and higher than 65 for PFII (Table 1), being PFII the most promising on this parameter. The composition of PFII could be related to its best performance, which shows a higher uronic acid and arabinose content than PFI.
Amastigote forms correspond to the intracellular multiplicative evolutionary stage found in the vertebrate host and intrinsically linked to the development of tissue parasitism, being of great importance for the development of the chronic form of the disease and their eradication is aimed at prospection of a new chemotherapeutic agent (Clayton 2010). Substances against amastigote forms were obtained from plants and they were similarly able to reduce parasite proliferation (Uchiyama et al. 2002). The fractionation of the methanolic extract of the leaves of Alchornea glandulosa resulted in an alkaloid of guanidine that exhibited antiprotozoal activity against amastigote forms of strain Y of T. cruzi, presenting an EC50 of 27 μg/ml (Barrosa et al. 2014). The antiamastigote effect of PFI and PFII was evaluated at 24 and 48 h. The fractions were tested on this form in two concentrations, EC50 and EC50/2, from trypomastigote forms. Our results demonstrated that in amastigote forms, the fractions of G. americana at a concentration of 100 μg/ml for PFI and 11.5 μg/ml and 23 μg/ml for PFII were able to decrease the number of infected cells, after 24 and 48 h of incubation. The same concentrations of the two fractions also can decrease the number of amastigotes/100 cells in both periods. PFI and PFII fractions showed better effects at 24 h of incubation. Besides, as noted, FII was more potent than FI, corroborating the effect of this fraction on trypomastigote forms (Fig. 1).
In this study, leading to the identification of the cell death mechanism induced by PFI of G. americana leaves, we initially analyzed the classical necrosis/apoptosis processes using fluorescent dyes 7-AAD and annexin V/PE (Kumar et al. 2015). This methodology allows the observation of cells in different populations: viable cells, which are not marked by any of the fluorochromes; necrotic cells, labeled only with 7-AAD; apoptotic cells, labeled only with annexin V/PE; double-labeled cells, which are considered in late apoptosis or secondary necrosis (Vanden Berghe et al. 2013). In this study, PFI treatment caused an increase in necrotic and secondary necrotic cells after 24 h of treatment compared to the untreated parasites, indicating alteration of cell membrane integrity (Fig. 2). PFII did not show any effect on epimastigote forms and cytometry analyses were not performed.
Necrosis involves changes in mitochondria including mitochondrial depolarization, ATP depletion, ROS generation, cytosolic vacuolization, loss of calcium homeostasis, and especially plasma membrane rupture (Menna-Barreto 2019). T. cruzi needs to deal with different redox microenvironments because they inhabit different biological compartments. Thus, this parasite has an extensive and differentiated mechanism of detoxification, which acts to protect it from the attack of oxidizing molecules (Irigoín et al. 2008). To verify if the polysaccharides studied are able to induce the production of ROS, DCFH-DA (a reagent that is converted into a fluorescent product in the presence of ROS in the cytoplasm) was used. Its mechanism allows us to observe the intracellular production of ROS, such as singlet oxygen, hydrogen peroxide, and superoxide anion (Chen et al. 2010). Our data showed that PFI of G. americana induces an increase of intracellular ROS, which may be associated with its trypanocidal effect (Fig. 3). Morphological alterations were also evaluated by SEM, in which ultrastructural changes in the typical format were observed, such as flattening and shortening of the parasite and degradation of the cell membrane with pores confirming necrosis induction (Fig. 4).
In conclusion, the arabinogalactan-glycoconjugate fractions are partially responsible by the trypanocidal effect of the crude extract of G. americana, with PFI showing the same action mechanism of crude extract (necrosis with an increase on ROS) and PFII being the most selective and potent fraction. The results showed PFI and PFII as promising substances for further experiments and development of new natural products to be a potential candidate for the treatment of Chagas disease.
References
Barrosa KH, Pinto EG, Tempone AG, Martins EGA, Lago JHG (2014) Alchornedine, a new anti-trypanosomal guanidine alkaloid from Alchornea glandulosa. Planta Med 80:1310–1314. https://doi.org/10.1055/s-0034-1382994
Berger I, Barrientos AC, Cáceres A, Hernández M, Rastrelli L, Passreiter CM, Kubelka W (1998) Plants used in Guatemala for the treatment of protozoal infections. II. Activity of extracts and fractions of five Guatemalan plants against Trypanosoma cruzi. J Ethnopharmacol 62:107–115. https://doi.org/10.1016/S0378-8741(98)00011-7
Cabral MMO, Barbosa-Filho JM, Maia GLA, Chaves MCO, Braga MV, De Souza W, Soares ROA (2010) Neolignans from plants in northeastern Brazil (Lauraceae) with activity against Trypanosoma cruzi. Exp Parasitol 124:319–324. https://doi.org/10.1016/j.exppara.2009.11.007
Chen X, Zhong Z, Xu Z, Chen L, Wang Y (2010) 2′,7′-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy. Free Radic Res 44:587–604. https://doi.org/10.3109/10715761003709802
Clayton J (2010) Chagas disease 101. Nature 465:S4–S5. https://doi.org/10.1038/nature09220
Corrêa PM (1984) Dicionário das plantas úteis do Brasil e das exóticas cultivadas. IBDF, Rio de Janeiro
da Rodrigues JHS, Ueda-Nakamura T, Corrêa AG, Sangi DP, Nakamura CV (2014) A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi. PLoS One 9:e85706. https://doi.org/10.1371/journal.pone.0085706
Deharo E, Bourdy G, Quenevo C, Muñoz V, Ruiz G, Sauvain M (2001) A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part V. Evaluation of the antimalarial activity of plants used by the Tacana Indians. J Ethnopharmacol 77:91–98. https://doi.org/10.1016/S0378-8741(01)00270-7
Don R, Ioset JR (2014) Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections [published correction appears in Parasitology. 2014 Jan;141(1):147]. Parasitology. 141:140–146. https://doi.org/10.1017/S003118201300142X
Irigoín F, Cibils L, Comini MA, Wilkinson SR, Flohé L, Radi R (2008) Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification. Free Radic Biol Med 45:733–742. https://doi.org/10.1016/j.freeradbiomed.2008.05.028
Izumi E, Ueda-Nakamura T, Dias Filho BP, Veiga Júnior VF, Nakamura CV (2011) Natural products and Chagas’ disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Nat Prod Rep 28:809–823. https://doi.org/10.1039/c0np00069h
Kffuri CW, Lopes MA, Ming LC, OdonneG KVF (2016) Antimalarial plants used by indigenous people of the Upper Rio Negro in Amazonas, Brazil. J Ethnopharmacol 178:188–198. https://doi.org/10.1016/j.jep.2015.11.048
Kumar G, Degheidy H, Casey BJ, Goering PL (2015) Flow cytometry evaluation of in vitro cellular necrosis and apoptosis induced by silver nanoparticles. Food Chem Toxicol 85:45–51. https://doi.org/10.1016/j.fct.2015.06.012
Lima DB, Sousa PL, Torres AFC, da Rodrigues KAF, Mello CP, Menezes RRPPB, Tessarolo LD, Quinet YP, de Oliveira MR, Martins AMC (2016) Antiparasitic effect of Dinoponera quadriceps giant ant venom. Toxicon 120:128–132. https://doi.org/10.1016/j.toxicon.2016.08.008
Lima DB, Mello CP, Bandeira ICJ, De Menezes RRPPB, Sampaio TL, Falcão CB, Morlighem JÉÉRL, Rádis-Baptista G, Martins AMC (2018) The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity. Biol Chem 399:187–196. https://doi.org/10.1515/hsz-2017-0198
Madeira JC, da Silva GVL, Batista JJ, Saraiva GD, Santos GRC, Assreuy AMS, Mourão PAS, Pereira MG (2018) An arabinogalactan-glycoconjugate from Genipa americana leaves present anticoagulant, antiplatelet and antithrombotic effects. Carbohydr Polym 202:554–562. https://doi.org/10.1016/j.carbpol.2018.09.003
Madeira JC, Farias LAS, Luz CP, Assreuy AMS, Pereira MG (2020) Per oral rat treatment with glyconjugate fractions of Genipa americana leaves protects thrombus formation. Blood Coagul Fibrinolysis 31:107–110. https://doi.org/10.1097/MBC.0000000000000880
Mafezoli J, Vieira PC, Fernandes JB, Da Silva MFGF, De Albuquerque S (2000) In vitro activity of Rutaceae species against the trypomastigote form of Trypanosoma cruzi. J Ethnopharmacol 73:335–340. https://doi.org/10.1016/S0378-8741(00)00315-9
Menna-Barreto RFS (2019) Cell death pathways in pathogenic trypanosomatids: lessons of (over) kill. Cell Death Dis 10:93. https://doi.org/10.1038/s41419-019-1370-2
Molina I, Salvador F, Sánchez-Montalvá A, Treviño B, Serre N, Sao Avilés A, Almirante B (2015) Toxic profile of benznidazole in patients with chronic Chagas disease: risk factors and comparison of the product from two different manufacturers. Antimicrob Agents Chemother 59:6125–6131. https://doi.org/10.1128/AAC.04660-14
Morais TR, Conserva GAA, Varela MT, Costa-Silva TA, Thevenard F, Ponci V, Fortuna A, Falcão AC, Tempone AG, Fernandes JPS, Lago JHG (2020) Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A. Sci Rep 10:5467. https://doi.org/10.1038/s41598-020-62352-w
Morais-Braga MFB, Souza TM, Santos KKA, Guedes GMM, Andrade JC, Vega C, Rolón M, Costa JGM, Saraiva AAF, Coutinho HDM (2013) Phenol composition, cytotoxic and anti-kinetoplastidae activities of Lygodium venustum SW. (Lygodiaceae). Exp Parasitol 134:178–182. https://doi.org/10.1016/j.exppara.2013.03.014
Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 83:770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
Noleto GR, Mercê AL, Iacomini M, Gorin PA, Soccol VT, Oliveira MB (2002) Effects of a lichen galactomannan and its vanadyl (IV) complex on peritoneal macrophages and leishmanicidal activity. Mol Cell Biochem 233:73–83. https://doi.org/10.1023/a:1015566312032
Nwaka S, Hudson A (2006) Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5:941–955. https://doi.org/10.1038/nrd2144
Souza ROS, Assreuy AMS, Madeira JC, Chagas FDS, Parreiras LA, Santos GRC, Mourão PAS, Pereira MG (2015) Purified polysaccharides of Geoffroea spinosa barks have anticoagulant and antithrombotic activities devoid of hemorrhagic risks. Carbohydr Polym 124:208–215. https://doi.org/10.1016/j.carbpol.2015.01.069
Souza ROS, Sousa PL, Menezes RRPPB, Sampaio TL, Tessarolo LD, Silva FCO, Pereira MG, Martins AMC (2018) Trypanocidal activity of polysaccharide extract from Genipa americana leaves. J Ethnopharmacol 210:311–317. https://doi.org/10.1016/j.jep.2017.08.042
Uchiyama N, Matsunaga K, Kiuchi F, Honda G, Tsubouchi A, Nakajima-Shimada J, Aoki T (2002) Trypanocidal terpenoids from Laurus nobilis L. Chem Pharm Bull 50:1514–1516. https://doi.org/10.1248/cpb.50.1514
Vanden Berghe T, Grootjans S, Goossens V, Dondelinger Y, Krysko DV, Takahashi N, Vandenabeele P (2013) Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods 61:117–129. https://doi.org/10.1016/j.ymeth.2013.02.011
WHO (2020) WHO | Epidemiology. Trypanosomiasis. World Health Organization, Geneve. https://www.who.int/news-room/facts-in-pictures/detail/chagas-disease. Accessed 23 August 2020
Acknowledgments
The author’s thanks Ms. Vanecia dos S. Gomes, who identified the plant species, and Professor Julia Manso Alves for the donation of cells and parasites (IQ-USP). We also are grateful to Analytic Center - UFC/CT - INFRA/Pro and CAPES Equipment.
Funding
This work was supported by the Brazilian grants Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Coordenação de Aperfeicoamento de Pessoal de Nível Superior (CAPES-PNPD fellowship of D. B. L., process number: 88887.368537/2019-00).
Author information
Authors and Affiliations
Contributions
ROSS: writing, review and editing, methodology, investigation; PLS, RRPPBM, TLS: methodology, investigation; DBL: writing, review, and editing; MGP: methodology, investigation, resources; AMCM: writing, review and editing, funding acquisition, conceptualization, resources. All the co-authors read and approved the manuscript. Furthermore, each author certifies that this material has not been and will not be submitted to or published in any other publication before its appearance in Brazilian Journal of Pharmacognosy.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
da Silva Souza, R.O., Sousa, P.L., de Menezes, R.R.P.P.B. et al. Arabinogalactan-Glycoconjugate Fractions from Genipa americana Leaves as a Source of Antichagasic Natural Products. Rev. Bras. Farmacogn. 30, 797–803 (2020). https://doi.org/10.1007/s43450-020-00110-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43450-020-00110-9